ACOR News and Press, Acorda Therapeutics Inc. From 11/02/21

Acorda Therapeutics, Inc. (NASDAQ: ACOR) will host a Webcast in conjunction with its third quarter 2021 update and financial results on Tuesday, November 9, at 4:30 p.m. ET. To participate in the Webcast, please use the following pre-registration link: https://event.on24.com...

Today, we take our first look at Acorda Therapeutics which has two approved products on the market. One of these is seeing increasing generic competition while the other is ramping up sales.  The company recently announced a significant workforce reduction to reduce costs. Ca...

Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...

Acorda Therapeutics (ACOR +2.5%) will cut its headcount by 15% to reduce costs and operating expenses, a move the company says will save $20M per year. Most of the cuts will take place immediately, with the entirety completed by Q1 2022. Acorda estimates it will incur $3M in pre-tax charges d...

15% reduction in headcount Greater than $20 million in expected annualized cost savings from headcount and budget reductions Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced a corporate restructuring to reduce costs and more closely align operating expenses with ...

Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...

Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...

Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...

The following slide deck was published by Acorda Therapeutics, Inc. in conjunction with their 2021 Q2 earnings call. For further details see: Acorda Therapeutics, Inc. 2021 Q2 - Results - Earnings Call Presentation

Acorda Therapeutics, Inc. (ACOR) Q2 2021 Earnings Conference Call August 5, 2021 04:30 PM ET Company Participants Tierney Saccavino - Executive Vice President-Corporate Communications Ron Cohen - Chief Executive Officer Conference Call Participants Muzamil Saleem - H.C. Wainwright Presentatio...